Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1993;2(4):303–307. doi: 10.1155/S0962935193000420

Mechanisms of tumor necrosis factor-α and interleukin-6 induction during human liver transplantation

Gerhard Hamilton 1,✉, Sonja Vogel 1, Reinhold Fuegger 1, Franz X M Gnant 1
PMCID: PMC2365415  PMID: 18475538

Abstract

In human orthotopic liver transplantation (LTX) intraoperative elevations of TNF-α (> 100 pg/ml) and IL-6 (>800 pg/ml) have been found to correlate with early post-operative rejections and infections respectively. In this study the possible mechanism responsible for the induction of these cytokines has been investigated during liver allografting in 38 recipients. Intraoperative elevations of TNF-α (> 100 pg/ml) were detected in the majority of pre-transplant endotoxin positive recipients (8/12, > 10 endotoxin units/ml), the patients turning endotoxin positive until the end of grafting (3/5), and in a subgroup (6/21 patients), apparently endotoxin negative for the whole operation. Therefore endotoxin (ET) seems to stimulate release of TNF-α in approximately 50% of the patients, whereas sensitized Kupffer graft cells or immediate allograft reactivity of the host are likely to account for the remaining TNF-α positive cases. Elevations of IL-6 > 800 pg/ml) were found in approximately 50% of the TNF-α positive cases, indicating partially independent regulatory pathways for IL-6 induction in the TNF-α negative patients. In agreement with a previous study, 11/13 (85%) of the intraoperative TNF-α positive recipients rejected their grafts within the first 10 days post-operatively. These data demonstrate that ET/infection associated as well as ET independent/reperfusion associated intraoperative TNF-α elevations, promote the initiation of allograft rejection in human liver transplantation. The transient and low endotoxaemia caused by the liver grafting procedure performed without veno-venous bypass seems to be of minor importance in the intraoperative induction of TNF-α.

Full Text

The Full Text of this article is available as a PDF (529.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger D., Marzinzig E., Marzinzig M., Beger H. G. Quantitative endotoxin determination in blood--chromogenic modification of the limulus amebocyte lysate test. Eur Surg Res. 1988;20(2):128–136. doi: 10.1159/000128751. [DOI] [PubMed] [Google Scholar]
  2. Függer R., Hamilton G., Steininger R., Mirza D., Schulz F., Mühlbacher F. Intraoperative estimation of endotoxin, TNF alpha, and IL-6 in orthotopic liver transplantation and their relation to rejection and postoperative infection. Transplantation. 1991 Aug;52(2):302–306. doi: 10.1097/00007890-199108000-00022. [DOI] [PubMed] [Google Scholar]
  3. Goto M., Takei Y., Kawano S., Tsuji S., Fukui H., Fushimi H., Nishimura Y., Kashiwagi T., Fusamoto H., Kamada T. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat. Hepatology. 1992 Aug;16(2):487–493. doi: 10.1002/hep.1840160230. [DOI] [PubMed] [Google Scholar]
  4. Halloran P. F., Wadgymar A., Autenried P. The regulation of expression of major histocompatibility complex products. Transplantation. 1986 Apr;41(4):413–420. [PubMed] [Google Scholar]
  5. Hamilton G., Prettenhofer M., Zommer A., Hofbauer S., Götzinger P., Gnant F. X., Függer R. Intraoperative course and prognostic significance of endotoxin, tumor necrosis factor-alpha and interleukin-6 in liver transplant recipients. Immunobiology. 1991 Aug;182(5):425–439. doi: 10.1016/s0171-2985(11)80207-x. [DOI] [PubMed] [Google Scholar]
  6. Hamilton G., Tüchy G., Hamilton B. Intraoperative kinetics and regional distribution of interleukin-6 during human liver transplantation. Transplantation. 1992 Oct;54(4):746–748. doi: 10.1097/00007890-199210000-00039. [DOI] [PubMed] [Google Scholar]
  7. Howard T. K., Klintmalm G. B., Cofer J. B., Husberg B. S., Goldstein R. M., Gonwa T. A. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation. 1990 Jan;49(1):103–107. doi: 10.1097/00007890-199001000-00023. [DOI] [PubMed] [Google Scholar]
  8. Imagawa D. K., Millis J. M., Olthoff K. M., Derus L. J., Chia D., Sugich L. R., Ozawa M., Dempsey R. A., Iwaki Y., Levy P. J. The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation. 1990 Aug;50(2):219–225. doi: 10.1097/00007890-199008000-00009. [DOI] [PubMed] [Google Scholar]
  9. Kraus T., Noronha I. L., Manner M., Klar E., Küppers P., Otto G. Clinical value of cytokine determination for screening, differentiation, and therapy monitoring of infectious and noninfectious complications after orthotopic liver transplantation. Transplant Proc. 1991 Feb;23(1 Pt 2):1509–1512. [PubMed] [Google Scholar]
  10. Mor E., Solomon H., Gibbs J. F., Holman M. J., Goldstein R. M., Husberg B. S., Gonwa T. A., Klintmalm G. B. Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome. Semin Liver Dis. 1992 Feb;12(1):28–40. doi: 10.1055/s-2007-1007374. [DOI] [PubMed] [Google Scholar]
  11. Quiroga J., Colina I., Demetris A. J., Starzl T. E., Van Thiel D. H. Cause and timing of first allograft failure in orthotopic liver transplantation: a study of 177 consecutive patients. Hepatology. 1991 Dec;14(6):1054–1062. [PubMed] [Google Scholar]
  12. Starzl T. E., Demetris A. J., Van Thiel D. Liver transplantation (2). N Engl J Med. 1989 Oct 19;321(16):1092–1099. doi: 10.1056/NEJM198910193211606. [DOI] [PubMed] [Google Scholar]
  13. Yokoyama I., Todo S., Miyata T., Selby R., Tzakis A. G., Starzl T. E. Endotoxemia and human liver transplantation. Transplant Proc. 1989 Oct;21(5):3833–3841. [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES